Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004393
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-10-18
Brief Title:
Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
Sponsor:
Organization:
Office of Rare Diseases ORD